Piramal Pharma Board of Directors
Get the latest insights into the leadership at Piramal Pharma. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Nandini Piramal | Chairperson |
| Peter DeYoung | Executive Director |
| Vivek Valsaraj | Whole Time Director & Chief Financial Officer |
| Peter Stevenson | Non Executive Independent Director |
| Jairaj Purandare | Non Executive Independent Director |
| Vibha Paul Rishi | Non Executive Independent Director |
| Sridhar Gorthi | Non Executive Independent Director |
| Amit Jain | Nominee Director of CA Alchemy Investments |
| Nathalie Leitch | Non Independent & Non Executive Director |
Piramal Pharma FAQs
The board at Piramal Pharma consists of experienced professionals, including Nandini Piramal, Peter DeYoung, and others, overseeing the company’s strategic and corporate governance.
Directors at Piramal Pharma are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Nandini Piramal is the current chairman at Piramal Pharma.
Executive directors at Piramal Pharma are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Piramal Pharma adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Piramal Pharma, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
